Biofilm Formation in Nonmultidrug-resistant Escherichia coli Isolated from Patients with Urinary Tract Infection in Isfahan, Iran

Document Type : Original Article


Department of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran


Background: Escherichia coli is a Gram-negative, opportunistic human pathogen in which increasing antibiotic resistance is a great concern for continued human survival. Although biofilm formation is a mechanism that helps E. coli to survive in unfavorable conditions, according to the importance of biofilm formation in developing the antibiotic resistance here, we studied the relation between antibiotic resistance and in vitro qualitative rating method biofilm formation in E. coli isolated from patients with urinary tract infection (UTI). Materials and Methods: The clinical isolates of E. coli (n = 100) were collected from urine of patients with UTI attending Isfahan Alzahra hospital. The strains were confirmed as E. coli using biochemical tests and molecular method. The Kirby-Bauer disk diffusion tests were done according to the Clinical and Laboratory Standards Institute protocol, and the biofilm synthesis was performed by microplate method. The binary logistic test was applied and P < 0.05 was considered statistically significant. Results: Our results showed a high outbreak of multidrug-resistant (MDR) E. coli strains (73%) and the highest resistance was observed toward ampicillin. The prevalence of biofilm producer isolates was 80% that 29% produced strong biofilm. The distribution of non-MDR isolates was high among strong biofilm producers, which shows a significant negative correlation between biofilm production and MDR pattern (P < 0.001). Conclusions: We found a negative correlation between MDR phenotype and biofilm formation capacity. This transmits the concept that more antibiotic susceptibility of strong biofilm producers may be due to the reduced exposure to multiple antibiotics.


Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015;13:269-84.  Back to cited text no. 1
Walker E, Lyman A, Gupta K, Mahoney MV, Snyder GM, Hirsch EB, et al. Clinical management of an increasing threat: Outpatient urinary tract infections due to multidrug-resistant uropathogens. Clin Infect Dis 2016;63:960-5.  Back to cited text no. 2
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med 2006;119:S20-8.  Back to cited text no. 3
Bradford PA. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.  Back to cited text no. 4
Garau J. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: Fosfomycin, nitrofurantoin and tigecycline. Clin Microbiol Infect 2008;14 Suppl 1:198-202.  Back to cited text no. 5
Gupta K, Bhadelia N. Management of urinary tract infections from multidrug-resistant organisms. Infect Dis Clin North Am 2014;28:49-59.  Back to cited text no. 6
Levin BR, Rozen DE. Non-inherited antibiotic resistance. Nat Rev Microbiol 2006;4:556-62.  Back to cited text no. 7
Crémet L, Corvec S, Batard E, Auger M, Lopez I, Pagniez F, et al. Comparison of three methods to study biofilm formation by clinical strains of Escherichia coli. Diagn Microbiol Infect Dis 2013;75:252-5.  Back to cited text no. 8
Ponnusamy P, Natarajan V, Sevanan M.In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Asian Pac J Trop Med 2012;5:210-3.  Back to cited text no. 9
Karimi S, Ghafourian S, Taheri Kalani M, Azizi Jalilian F, Hemati S, Sadeghifard N, et al. Association between toxin-antitoxin systems and biofilm formation. Jundishapur J Microbiol 2015;8:e14540.  Back to cited text no. 10
Tajbakhsh E, Ahmadi P, Abedpour-Dehkordi E, Arbab-Soleimani N, Khamesipour F. Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in iran. Antimicrob Resist Infect Control 2016;5:11.  Back to cited text no. 11
Saeed MA, Haque A, Ali A, Mohsin M, Bashir S, Tariq A, et al. Aprofile of drug resistance genes and integrons in E. coli causing surgical wound infections in the faisalabad region of Pakistan. J Antibiot (Tokyo) 2009;62:319-23.  Back to cited text no. 12
Danese PN, Pratt LA, Dove SL, Kolter R. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol 2000;37:424-32.  Back to cited text no. 13
Naves P, del Prado G, Huelves L, Gracia M, Ruiz V, Blanco J, et al. Measurement of biofilm formation by clinical isolates of Escherichia coli is method-dependent. J Appl Microbiol 2008;105:585-90.  Back to cited text no. 14
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.  Back to cited text no. 15
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010;35:322-32.  Back to cited text no. 16
Qi L, Li H, Zhang C, Liang B, Li J, Wang L, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol 2016;7:483.  Back to cited text no. 17
Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med 2016;7:22-6.  Back to cited text no. 18
Tajbakhsh E, Khamesipour F, Ranjbar R, Ugwu IC. Prevalence of class 1 and 2 integrons in multi-drug resistant Escherichia coli isolated from aquaculture water in Chaharmahal va Bakhtiari province, Iran. Ann Clin Microbiol Antimicrob 2015;14:37.  Back to cited text no. 19
Karimi S, Ghafourian S, Taheri Kalani M, Azizi Jalilian F, Hemati S, Sadeghifard N, et al. Association between toxin-antitoxin systems and biofilm formation. Jundishapur J Microbiol 2014;8:e14540.  Back to cited text no. 20
Eyoh AB, Toukam M, Atashili J, Fokunang C, Gonsu H, Lyonga EE, et al. Relationship between multiple drug resistance and biofilm formation in Staphylococcus aureus isolated from medical and non-medical personnel in Yaounde, Cameroon. Pan Afr Med J 2014;17:186.  Back to cited text no. 21
Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P, et al. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from Intensive Care Unit. Indian J Crit Care Med 2013;17:214-8.  Back to cited text no. 22
[PUBMED]  [Full text]  
Perez LR. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J Chemother 2015;27:13-6.  Back to cited text no. 23
Alves MJ, Barreira JC, Carvalho I, Trinta L, Perreira L, Ferreira IC, et al. Propensity for biofilm formation by clinical isolates from urinary tract infections: Developing a multifactorial predictive model to improve antibiotherapy. J Med Microbiol 2014;63:471-7.  Back to cited text no. 24
Ceri H, Olson M, Morck D, Storey D, Read R, Buret A, et al. The MBEC assay system: Multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol 2001;337:377-85.  Back to cited text no. 25
Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:34-9.  Back to cited text no. 26